Do the patient and pharmacist need to sign to confirm the release of Opioid Agonist Treatment (i.e. methadone, morphine or buprenorphine for maintenance)?

Yes, prior to releasing the first OAT dose of a prescription, the pharmacist and the patient must sign the Controlled Prescription Program form in the space at the bottom of the form to confirm the patient has received the first dose of the prescription. The patient and pharmacist must also sign the patient/prescription-specific log to acknowledge the receipt of each witnessed ingestion dose, each partial dose and each take- home dose.

Neither the pharmacist nor the patient is permitted to pre-sign for future doses. The pharmacist must store the signed prescription and the patient/prescription-specific log together.